Pioglitazone, but not gliclazide or metformin, improves the adipokine profile of overweight type 2 diabetes patients independent of glycaemic control

J Reid, J M Lawrence, G J Taylor, C A Stirling, J P D Reckless

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)330-330
Number of pages1
JournalAtherosclerosis Supplements
Issue number3
Publication statusPublished - 2006

Cite this